Ardelyx Inc (ARDX)

0.8482 -0.01  -1.61% NASDAQ Nov 30, 14:06 USD
View Full Chart
Price Chart
View All ARDX News

News

View All Events

Events

Date Type Description
03/08/2022 Earnings Results Q4 2021 Earnings Results
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/13/2021 Earnings Results Q2 2021 Earnings Results
06/16/2021 11:30 EST AGM 2021 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/08/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
  • URL: https://www.ardelyx.com
  • Investor Relations URL: https://ir.ardelyx.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 08, 2022
  • Last Earnings Release: Nov. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.